Cargando…
Increased levels of active c-Src distinguish invasive from in situ lobular lesions
INTRODUCTION: Mounting molecular evidence suggests that invasive lobular carcinoma (ILC) is developing from in situ lesions, atypical lobular hyperplasia (ALH), and lobular carcinoma in situ (LCIS). However, little is known about the mechanisms promoting the progression of lobular breast cancer (LBC...
Autores principales: | Zou, Donghui, Yoon, Han-Seung, Anjomshoaa, Ahmad, Perez, David, Fukuzawa, Ryuji, Guilford, Parry, Humar, Bostjan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750104/ https://www.ncbi.nlm.nih.gov/pubmed/19583841 http://dx.doi.org/10.1186/bcr2332 |
Ejemplares similares
-
A short guide to hereditary diffuse gastric cancer
por: Guilford, Parry, et al.
Publicado: (2007) -
Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer
por: Yates, LR, et al.
Publicado: (2010) -
Comparison of the Imaging Features of Lobular Carcinoma In Situ and Invasive Lobular Carcinoma of the Breast
Publicado: (2021) -
The diagnosis and management of pre-invasive breast disease: Pathology of atypical lobular hyperplasia and lobular carcinoma in situ
por: Simpson, Peter T, et al.
Publicado: (2003) -
Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions
por: Andrade, Victor P, et al.
Publicado: (2012)